Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Business Wire•13/10/2026•08:00 ET
0
Key Highlights
- ➤Coya Therapeutics (COYA) will participate in Chardan’s 10th Annual Healthcare Conference panel October 20.
- ➤Fred Grossman, Coya’s president and chief medical officer, will represent the company on the panel.
- ➤Coya management will be available for one-on-one investor meetings.
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced the company will be participating in a panel discussion at Chardan's 10th Annual Healthcare Conference taking place on October 20 in New York.
Get started
Create a free account to read the full story.